USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/8564
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArteni, Ion
dc.contributor.authorȚîbîrnă, Ion
dc.contributor.authorSavin, Victor
dc.date.accessioned2020-04-21T12:27:19Z
dc.date.available2020-04-21T12:27:19Z
dc.date.issued2012
dc.identifier.citationARTENI, I., ŢÎBÎRNĂ, I., SAVIN, V. Terapia antirecidivantă în ulcerele duodenale cu multiple defecte. In: Curierul Medical. 2012, nr. 3(327), pp. 23-25. ISSN 1875-0666.en_US
dc.identifier.issn1875-0666
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2016/09/18.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/8564
dc.descriptionDepartment of Internal Medicine No 3, Nicolae Testemitanu State Medical and Pharmaceutical University, Congresul III al Medicilor de Familie din Republica Moldova, 17–18 mai, 2012, Chişinău, Republica Moldova, Conferinţa Naţională „Maladii bronhoobstructive la copii”, consacrată profesorului universitar, doctor habilitat Victor Gheţeul, 27 aprilie, Chişinău, Republica Moldovaen_US
dc.description.abstractThe result of a performed study made on 52 patients with multiple duodenal ulcers has established a high frequency – 31.0% of ulcer recurrence after was confirmated the clinico-endoscopic remission durring first year. The continuous and intermittent treatment administrated with antysecretory preparations (blockers of histamine H2-receptors) to 52 patients with multiple duodenal ulcers in the remission period had decreased the risk of ulcers recurrence by 2.0–4.0% in supervised period of time.en_US
dc.description.abstractВ результате проведенных исследований, у 52 больных с множественными дуоденальными язвами, после наступления клиникоэндоскопической ремиссии, которые не получали потиворецидивирующее лечение на протяжении первого года наблюдения, была определена увеличенная частота (31,0%) рецидивов язв двенадцатиперстной кишки. Полученное постоянное и интермитентное поддерживающее лечение с антисекреторными препаратами (блокаторы Н2 гистаминовых рецепторов) у 52 больных в период ремиссии язвенной болезни двенадцатиперстной кишки уменьшило риск развития язвенных рецидивов до 2,0–4,0%.
dc.language.isoroen_US
dc.publisherMinisterul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”en_US
dc.relation.ispartofCurierul Medical: Congresul III al Medicilor de Familie din Republica Moldova, 17–18 mai, 2012, Chişinău, Republica Moldova, Conferinţa Naţională „Maladii bronhoobstructive la copii”, consacrată profesorului universitar, doctor habilitat Victor Gheţeul, 27 aprilie, Chişinău, Republica Moldova
dc.subjectmultiple duodenal ulcersen_US
dc.subjectcontinuous and intermittent treatmenten_US
dc.titleTerapia antirecidivantă în ulcerele duodenale cu multiple defecteen_US
dc.title.alternativeAnti-relapse therapy of multiple duodenal ulcersen_US
dc.title.alternativeПротиворецидивирующее лечение множественных дуоденальных язвen_US
dc.typeArticleen_US
Appears in Collections:Curierul Medical, 2012, Vol. 327, Nr. 3

Files in This Item:
File Description SizeFormat 
Terapia_antirecidivanta_in_ulcerele_duodenale_cu_multiple_defecte.pdf183.95 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback